In Q2 fiscal 2026 (the quarter ended June 30, 2026), CVS Health's largest business segment was Health Services, with $51.80 billion or 42% of revenue, up 11.5% from a year earlier. Next: Health Care Benefits (30%) and Pharmacy and Consumer Health (27%).
By product or service, Pharmacy Revenue brought in 58%, Premiums brought in 33% and Front Store Revenue brought in 5% of revenue in Q2 fiscal 2026.
The fastest-growing business segment from a year earlier was Health Services (+11.5%).
From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q3 fiscal 2017.

Fiscal quarters, from company filings
| Business segment | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Health Services | $51.8B | $48.2B | $49.3B | $46.5B | 42% |
| Health Care Benefits | $37.5B | $36.0B | $36.0B | $36.3B | 30% |
| Pharmacy and Consumer Health | $33.8B | $32.0B | $36.2B | $33.6B | 27% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
| Product or service | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Pharmacy Revenue | $60.8B | $56.9B | $59.5B | $55.3B | 58% |
| Premiums | $35.1B | $33.8B | $33.7B | $34.2B | 33% |
| Front Store Revenue | $5.4B | $5.3B | $5.2B | $5.4B | 5% |
| Other | $4.1B | $3.9B | $3.8B | $3.5B | 4% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Health Services, Health Care Benefits and Pharmacy and Consumer Health (as reported for Q2 fiscal 2026).
Health Services: $51.80 billion, or 42% of revenue, in Q2 fiscal 2026.
By revenue in Q2 fiscal 2026: Pharmacy Revenue (58%), Premiums (33%), Front Store Revenue (5%) and Other (4%).
Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i
Fiscal quarter ended Jun 30, 2026
| Item | Revenue | Share |
|---|---|---|
| Health Services | USD 51.80B | 42.1% |
| Health Care Benefits | USD 37.54B | 30.5% |
| Pharmacy and Consumer Health | USD 33.82B | 27.5% |
| Corporate and Other - Corporate and Reconciling Itemsi | USD 147.00M | |
| Intersegment eliminationsi | -USD 17.20B |
Sum of items USD 123.15B; corporate items and eliminations -USD 17.05B. Shares are of the items shown. Click an item with › to see its parts.
Every item and period in one grid. Purple = calculated; "–" = not available.
| Item | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 | Q4 FY23 | Q3 FY23 | Q2 FY23 | Q1 FY23 | Q4 FY22 | Q3 FY22 | Q2 FY22 | Q1 FY22 | Q4 FY21 | Q3 FY21 | Q2 FY21 | Q1 FY21 | Q4 FY20 | Q3 FY20 | Q2 FY20 | Q1 FY20 | Q4 FY19 | Q3 FY19 | Q2 FY19 | Q1 FY19 | Q4 FY18 | Q3 FY18 | Q2 FY18 | Q1 FY18 | Q4 FY17 | Q3 FY17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Health Care Benefits | 37.5B | 36.0B | 36.3B | 36.0B | 36.3B | 34.8B | 33.0B | 33.0B | 32.5B | 32.2B | 26.7B | 26.3B | 26.7B | 25.9B | 23.0B | 22.5B | 22.6B | 23.1B | 20.5B | 20.5B | 20.5B | 20.5B | 19.1B | 18.6B | 18.3B | 19.1B | 17.1B | 17.2B | 17.4B | 17.9B | – | 641.0M | 764.0M | 1.3B | – | – |
| Health Services | 51.8B | 48.2B | 51.2B | 49.3B | 46.5B | 43.5B | 47.0B | 44.1B | 42.2B | 40.3B | 49.1B | 46.9B | 46.2B | 44.6B | – | 43.3B | 39.9B | 39.6B | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Pharmacy Services | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 43.7B | – | – | – | 37.3B | 39.0B | 38.3B | 36.3B | 36.4B | 35.7B | 34.9B | 35.0B | 37.1B | 36.0B | 34.8B | 33.6B | – | 33.9B | 33.4B | 32.5B | – | 32.9B |
| Pharmacy and Consumer Health | 33.8B | 32.0B | 37.7B | 36.2B | 33.6B | 31.9B | 33.5B | 32.4B | 29.8B | 28.7B | 31.2B | 28.9B | 28.8B | 27.9B | – | 27.2B | 17.9B | 25.9B | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Retail Long-Term Care | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 28.2B | – | – | – | 18.4B | 25.0B | 24.7B | 23.3B | 24.1B | 22.7B | 21.7B | 22.7B | 22.6B | 21.5B | 21.4B | 21.1B | – | 20.9B | 20.7B | 20.4B | – | – |
| Retail L T C | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 19.6B |
| Corporate and Other - Corporate and Reconciling Items | 147.0M | 126.0M | 122.0M | 133.0M | 96.0M | 133.0M | 83.0M | 142.0M | 111.0M | 115.0M | 75.0M | 105.0M | 83.0M | 188.0M | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Corporate and other | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 152.0M | – | 34.0M | – | 24.0M | 171.0M | 182.0M | 135.0M | 134.0M | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Corporate / Other | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 217.0M | 210.0M | 48.0M | – | – |